Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development
- PMID: 24480529
- PMCID: PMC4081457
- DOI: 10.1016/j.jpainsymman.2013.07.018
Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development
Abstract
Context: Delirium is a highly prevalent complication in patients in palliative care settings, especially in the end-of-life context.
Objectives: To review the current evidence base for treating episodes of delirium in palliative care settings and propose a framework for future development.
Methods: We combined multidisciplinary input from delirium researchers and other purposely selected stakeholders at an international delirium study planning meeting. This was supplemented by a literature search of multiple databases and relevant reference lists to identify studies regarding therapeutic interventions for delirium.
Results: The context of delirium management in palliative care is highly variable. The standard management of a delirium episode includes the investigation of precipitating and aggravating factors followed by symptomatic treatment with drug therapy. However, the intensity of this management depends on illness trajectory and goals of care in addition to the local availability of both investigative modalities and therapeutic interventions. Pharmacologically, haloperidol remains the practice standard by consensus for symptomatic control. Dosing schedules are derived from expert opinion and various clinical practice guidelines as evidence-based data from palliative care settings are limited. The commonly used pharmacologic interventions for delirium in this population warrant evaluation in clinical trials to examine dosing and titration regimens, different routes of administration, and safety and efficacy compared with placebo.
Conclusion: Delirium treatment is multidimensional and includes the identification of precipitating and aggravating factors. For symptomatic management, haloperidol remains the practice standard. Further high-quality collaborative research investigating the appropriate treatment of this complex syndrome is needed.
Keywords: Delirium; decision making; evidence-based medicine; hospices; palliative care; therapeutics.
Copyright © 2014 American Academy of Hospice and Palliative Medicine. All rights reserved.
Similar articles
-
Clinical practice guidelines for delirium management: potential application in palliative care.J Pain Symptom Manage. 2014 Aug;48(2):249-58. doi: 10.1016/j.jpainsymman.2013.09.023. Epub 2014 Apr 21. J Pain Symptom Manage. 2014. PMID: 24766743 Free PMC article. Review.
-
Interventions for preventing intensive care unit delirium in adults.Cochrane Database Syst Rev. 2018 Nov 23;11(11):CD009783. doi: 10.1002/14651858.CD009783.pub2. Cochrane Database Syst Rev. 2018. PMID: 30484283 Free PMC article.
-
Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit.Cochrane Database Syst Rev. 2020 Feb 28;2(2):CD012670. doi: 10.1002/14651858.CD012670.pub2. Cochrane Database Syst Rev. 2020. PMID: 32108325 Free PMC article.
-
Benzodiazepines and/or neuroleptics for the treatment of delirium in palliative care?-a critical appraisal of recent randomized controlled trials.Ann Palliat Med. 2019 Sep;8(4):504-515. doi: 10.21037/apm.2019.03.06. Epub 2019 Mar 26. Ann Palliat Med. 2019. PMID: 30943743 Review.
-
Comparison of haloperidol, non-haloperidol antipsychotics, and no pharmacotherapy for the management of delirium in an inpatient geriatric palliative care population.J Pain Palliat Care Pharmacother. 2018 Jun-Sep;32(2-3):141-148. doi: 10.1080/15360288.2018.1513434. J Pain Palliat Care Pharmacother. 2018. PMID: 31066639
Cited by
-
The Relationship of Post-traumatic Stress Disorder to End-of-life Care Received by Dying Veterans: a Secondary Data Analysis.J Gen Intern Med. 2020 Feb;35(2):505-513. doi: 10.1007/s11606-019-05538-x. Epub 2019 Dec 2. J Gen Intern Med. 2020. PMID: 31792872 Free PMC article. Clinical Trial.
-
The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center.Support Care Cancer. 2015 Aug;23(8):2427-33. doi: 10.1007/s00520-015-2610-3. Epub 2015 Jan 24. Support Care Cancer. 2015. PMID: 25617070
-
An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectives.J Pain Symptom Manage. 2014 Aug;48(2):159-175. doi: 10.1016/j.jpainsymman.2013.12.245. Epub 2014 Apr 12. J Pain Symptom Manage. 2014. PMID: 24726762 Free PMC article.
-
Quality of clinical practice guidelines in delirium: a systematic appraisal.BMJ Open. 2017 Mar 10;7(3):e013809. doi: 10.1136/bmjopen-2016-013809. BMJ Open. 2017. PMID: 28283488 Free PMC article.
-
Cognition, anesthesia, and surgery.Int Anesthesiol Clin. 2014 Fall;52(4):42-57. doi: 10.1097/AIA.0000000000000032. Int Anesthesiol Clin. 2014. PMID: 25268863 Free PMC article. Review. No abstract available.
References
-
- Hosie A, Davidson PM, Agar M, Sanderson CR, Phillips J. Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review. Palliat Med. 2013;27:486–498. - PubMed
-
- Agar M, Lawlor P. Delirium in cancer patients: a focus on treatment-induced psychopathology. Curr Opin Oncol. 2008;20:360–366. - PubMed
-
- Caraceni A, Nanni O, Maltoni M, et al. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer. 2000;89:1145–1149. - PubMed
-
- Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006;35:350–364. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical